News

Filter

Benefits of Diane 35 and generics outweigh risks in specific patient group, says EMA unit; other actions

17-05-2013

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has concluded that…

almitrineAnti-Arthritics/RheumaticsBayerDermatologicalsDiane-35EuropeOsseorPharmaceuticalProtelosRegulation

EMA backs Protelos and Osseor, but with warnings

19-03-2012

The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has finalized a review…

Anti-Arthritics/RheumaticsEuropeOsseorPharmaceuticalProtelosRegulationServier

EMA says risk-benefit of ARBs positive; acts on Advagraf and Protelos/Osseor

21-10-2011

In a flurry of late news yesterday from the European Medicines Agency and its Committee for Medicinal…

AdvagrafAnti-Arthritics/RheumaticsAstellas PharmaCardio-vascularEuropeImmunologicalsPharmaceuticalProtelosRegulationServier

UK’s NICE backs Abilify for teenagers; sticks with guidance on Servier’s Protelos

27-01-2011

In final guidance published yesterday, the UK’s National Institute for Health and Clinical Excellence…

AbilifyAnti-Arthritics/RheumaticsBristol-Myers SquibbEuropeNeurologicalOtsukaPharmaceuticalProtelosRegulationServier

Servier’s Protelos builds stronger bone compared to bisphosphonates, study shows

22-06-2010

French independent drugmaker Laboratoires Servier’s osteoporosis treatment Protelos (strontium ranelate)…

Anti-Arthritics/RheumaticsPharmaceuticalProtelosResearchServier

Back to top